T CELL-DEPENDENT ACCELERATION OF CHEMOATTRACTANT CYTOKINE GENE EXPRESSION DURING SECONDARY REJECTION OF ALLOGENEIC SKIN GRAFTS1
- 15 March 1997
- journal article
- immunobiology
- Published by Wolters Kluwer Health in Transplantation
- Vol. 63 (5) , 732-742
- https://doi.org/10.1097/00007890-199703150-00021
Abstract
Chemoattractant cytokines, chemokines, are likely to play a critical role in directing leukocytes to graft sites and in amplifying intragraft inflammation during rejection. Since second-set graft rejection occurs at an accelerated rate, we hypothesized that chemokine genes would be expressed earlier during secondary allograft rejection than during rejection of primary allografts. We have tested this hypothesis by using Northern blot analysis to compare intragraft expression levels of genes encoding interleukin (IL) 1β and six chemokines during rejection of C57BL/6 skin grafts on naive and C57BL/6-sensitized BALB/c recipients. Expression levels of IL-1β, interferon-γ inducible protein, macrophage inflammatory protein-1 (MIP-1) α, and MIP-1β genes were 10- to 17-fold higher on day 5 after transplantation in C57BL/6 grafts on C57BL/6-presensitized recipients than in C57BL/6 grafts on unprimed recipients. Intragraft expression of the chemokines regulated upon activation, normal T cell expressed and secreted (RANTES), during primary C57BL/6 graft rejection was virtually undetectable at day 7 after primary transplantation, but was expressed at high levels by day 5 after secondary transplantation. In third-party CBA/Ca allografts on unsensitized and C57BL/6-presensitized BALB/c mice, similar levels of IL-1β, MIP-1α, and MIP-1β expression were observed. High levels of RANTES and interferon-γ inducible protein expression, however, were observed at day 5 after transplantation in CBA/Ca grafts on C57BL/6-presensitized recipients and correlated with accelerated rejection of the third-party grafts. Although T cells from C57BL/6-presensitized recipients did not express increased reactivity to CBA/Ca stimulator cells in vitro, serum antibodies from these recipients demonstrated reactivity to cells from CBA/Ca and A/J mice. When compared with transfer of unprimed cells, transfer of C57BL/6-primed lymphoid cells to sublethally irradiated BALB/c mice engrafted with C57BL/6 grafts resulted in increased intragraft proinflammatory cytokine gene expression. Deletion of T cells before transfer abrogated the increased intragraft expression of proinflammatory cytokine genes. Collectively, these results indicate that the accelerated expression of chemokine genes during second-set rejection of allogeneic skin grafts is mediated by immune T cells.Keywords
This publication has 39 references indexed in Scilit:
- Alterations In Renal Interleukin-1 Production During Kidney Transplant Rejection In The RatTransplantation, 1993
- THE CLINICAL SIGNIFICANCE OF ALLOSPECIFIC ANTIBODIES AGAINST ENDOTHELIAL CELLS DETECTED WITH AN ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY ASSAY FOR VASCULAR REJECTION AND GRAFT LOSS AFTER RENAL TRANSPLANTATIONTransplantation, 1993
- CELLS MEDIATING ALLOGRAFT REJECTIONTransplantation, 1991
- Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine FamilyAnnual Review of Immunology, 1991
- Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTESNature, 1990
- A macrophage LPS-inducible early gene encodes the murine homologue of IP-10Biochemical and Biophysical Research Communications, 1990
- Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties.The Journal of Experimental Medicine, 1988
- Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection.The Journal of Experimental Medicine, 1987
- Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).The Journal of Experimental Medicine, 1987
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984